< i > New England Journal of Medicine < /i > publishes COVID-19 treatment trial results
(University of Texas Health Science Center at San Antonio) In a multicenter study funded by the National Institutes of Health, a combination of two drugs, baricitinib and remdesivir, reduced time to recovery in hospitalized COVID-19 patients. The results from sites including UT Health San Antonio and University Health were published Dec. 11 in theNew England Journal of Medicine.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: COVID-19 | Infectious Diseases | National Institutes of Health (NIH) | Science | Study | Texas University